High purity, bioactive recombinant growth factor and cytokine proteins for stem cell, organoid and regenerative medicine.
Location: United Kingdom, England, Milton Keynes
Total raised: $8.21M
Investors 4
| Date | Name | Website |
| - | o2h ventur... | o2hventure... |
| 01.12.2022 | Cambridge ... | cambridgea... |
| - | Parkwalk A... | parkwalkad... |
| - | Martlet | martletcap... |
Funding Rounds 3
| Date | Series | Amount | Investors |
| 23.12.2022 | - | $5.47M | - |
| 09.06.2020 | Series A | $2.04M | - |
| 03.06.2019 | - | $696.5K | - |
Mentions in press and media 20
| Date | Title | Description |
| 06.09.2024 | Qkine expands senior leadership | Qkine expands senior leadership with the appointment of Rob Nixon, Commercial Director, and Paul Grafham, Chief Financial Officer. Qkine is delighted to announce the appointment of Rob Nixon to its leadership team as Commercial Director and... |
| 28.07.2023 | Meet the founder: ORF Genetics’ Dr. Björn Örvar on why barley could unlock the potential of cultivated meat | Growth factors—signaling proteins used to stimulate cell growth and differentiation in cultivated meat production—come with a hefty price tag, putting pressure on firms to express them more efficiently in everything from fruit flies to micr... |
| 26.07.2023 | Qkine announces collaboration with Sartorius | Qkine, a manufacturer of animal-free, highly bioactive, and innovative proteins, announces its collaboration with Sartorius, a global life science group, to supply growth factors and cytokines for stem cell and organoid research, as part of... |
| 06.07.2023 | Qkine and Sartorius Partnership Delivers a Complete Workflow Solution for the Analysis of Advanced Cell Models | Sartorius to commercialise Qkine growth factors and cytokines as part of a complete workflow solution for stem cell and organoid research Cell type-specific application data on Sartorius instruments streamline process and speed up time to r... |
| 07.02.2023 | #21toWatch announces shortlist of next generation of Cambridge game-changers set for future success | cofinitive have announced the shortlist for #21toWatch 2023 which this year contains an eclectic mix of industries – biotech, cleantech, agritech, construction, automotive, deep learning, marine, life sciences, AI – all sharing the same mis... |
| 12.01.2023 | Oxford Innovation invest in Qkine’s £4.3 million fund raise | Oxford Innovation EIS Growth Fund and OION Angels invest 14% of Qkine’s latest £4.3 million fund raise which was co-led by Parkwalk Advisors Ltd and Downing Ventures. |
| 23.12.2022 | Qkine – raises £4.3m in latest funding round | We’re delighted to announce our recent investment in Qkine, as part of a £4.3m funding round. The University of Cambridge spin-out has designed a proprietary refolding technology and protein purification technique to produce high quality gr... |
| 15.12.2022 | Qkine raises £4.3m scale-up capital and prepares HQ move | - |
| 15.12.2022 | Qkine Raises Over £4M in Funding | Qkine, a Cambridge, UK-based manufacturer of animal-free, bioactive, and innovative proteins and growth factors for life science applications, raised £4M in funding. The round was led by Parkwalk Advisors Ltd and Downing Ventures. The compa... |
| 15.12.2022 | Qkine Raises Over £4 Million to Scale Manufacturing, R&D and Commercial Functions | Qkine Ltd, a manufacturer of animal-free, highly bioactive, and innovative proteins and growth factors for life science applications, announces the close of its oversubscribed funding raise, having secured £4.3M. The round, which was co-led... |
Show more